TIRZEPATIDE : A THOROUGH LOOK

The emerging class of GLP-1 receptor agonist and GIP combined medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, represent significant improvements in diabetes management . Although all three work by impacting sugar readings , they vary in their specific mechan